NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

But yet, ten well-qualified neuro-oncologists challenged the validity of the NWBO P3 trial. Not often that multiple articles/comments are posted questioning the validity of the trial conclusions. Are both now part of the searchable history of the NWBO publication history so any clinician can read the challenges when they search this study.


Does the following sound familiar?

"Let me tell you, we are acutely aware of all of the attacks. The attacks are just incessant, they're relentless. But we'll say that we find it quite shocking that even doctors associated with companies and that have competing technologies have indulged in attacks that have used fault information, false claims about our trial, how it was conducted, et cetera. "